PureTech Health plc (PTCHF)
Develops experimental medicines for lung disease, depression, and neurological conditions
$1.80+0.13%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-13.6%
The outlook
PTCHF is trading above both its 50- and 200-day moving averages, positioning it in the upper half of its 52-week range. Analyst coverage appears thin, so detailed rating data isn't available. The current technical setup leans constructive, though the stock remains modest in price at $1.80.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range69% of the way from its 52-week low to high
Market cap
$438.2M
52-wk high
$1.92
52-wk low
$1.53
50-day avg
$1.70
200-day avg
$1.69
Trailing P/E
—